Plasma CellsMultiple MyelomaBone MarrowBone Marrow TransplantationBone Marrow CellsParaproteinemiasHematopoietic Stem Cell TransplantationTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousBone and BonesPrognosisFlow CytometryGraft vs Host DiseaseTransplantation ConditioningParaproteinsB-LymphocytesHematopoietic Stem CellsStem CellsWhole-Body IrradiationTransplantation ChimeraPeripheral Blood Stem Cell TransplantationLiver TransplantationAmyloidosisBone Marrow DiseasesGraft SurvivalTissue DonorsLeukemiaAnemia, AplasticBone Marrow PurgingBone Marrow ExaminationHematologic NeoplasmsBusulfanBone RemodelingHistocompatibility TestingBone Marrow NeoplasmsHematopoiesisTreatment OutcomeHistocompatibilityKidney TransplantationMice, Inbred C57BLCell DifferentiationCyclophosphamideRecurrenceCombined Modality TherapyTime FactorsTransplantation, IsogeneicRemission InductionLeukemia, Myeloid, AcuteBone DensityImmunosuppressive AgentsMesenchymal Stem Cell TransplantationRadiation ChimeraLeukemia, Myelogenous, Chronic, BCR-ABL PositiveColony-Forming Units AssayCord Blood Stem Cell TransplantationRetrospective StudiesGraft RejectionBone ResorptionPrecursor Cell Lymphoblastic Leukemia-LymphomaCell TransplantationCells, CulturedTransplantation ImmunologyMyelodysplastic SyndromesAntigens, CD34Hepatic Veno-Occlusive DiseaseMelphalanSurvival AnalysisLymphoma, Non-HodgkinHeart TransplantationT-LymphocytesLeukemia, Plasma CellLeukemia, MyeloidLymphocyte DepletionImmunosuppressionHematologic DiseasesAntineoplastic Combined Chemotherapy ProtocolsAcute DiseaseHematopoietic Stem Cell MobilizationGraft vs Leukemia EffectGranulocyte Colony-Stimulating FactorHLA AntigensSurvival RateBone NeoplasmsLung TransplantationDisease-Free SurvivalLymphocyte TransfusionMyeloablative AgonistsFollow-Up StudiesSevere Combined ImmunodeficiencySpleenGraft vs Tumor EffectCell SeparationChimeraMesenchymal Stromal CellsCell LineageOrgan TransplantationCytarabinePancytopeniaImmunophenotyping